David P. Richman - Publications

Affiliations: 
Neuroscience University of California, Davis, Davis, CA 
Area:
Neuroscience Biology, Immunology

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Borges LS, Richman DP. Muscle-Specific Kinase Myasthenia Gravis. Frontiers in Immunology. 11: 707. PMID 32457737 DOI: 10.3389/Fimmu.2020.00707  0.35
2016 Richman DP. Lipoprotein-like receptor 4 antibodies in myasthenia gravis: pathogenic or protective. European Journal of Neurology. 23: 1593-1594. PMID 27753233 DOI: 10.1111/Ene.13169  0.376
2014 Morell SW, Trinh VB, Gudipati E, Friend A, Page NA, Agius MA, Richman DP, Fairclough RH. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor. Molecular Immunology. 58: 116-31. PMID 24333757 DOI: 10.1016/J.Molimm.2013.11.005  0.323
2012 Richman DP, Nishi K, Ferns MJ, Schnier J, Pytel P, Maselli RA, Agius MA. Animal models of antimuscle-specific kinase myasthenia. Annals of the New York Academy of Sciences. 1274: 140-7. PMID 23252909 DOI: 10.1111/J.1749-6632.2012.06782.X  0.337
2012 Richman DP, Nishi K, Morell SW, Chang JM, Ferns MJ, Wollmann RL, Maselli RA, Schnier J, Agius MA. Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes. Archives of Neurology. 69: 453-60. PMID 22158720 DOI: 10.1001/Archneurol.2011.2200  0.363
2012 Richman DP. Antibodies to low density lipoprotein receptor-related protein 4 in seronegative myasthenia gravis. Archives of Neurology. 69: 434-5. PMID 22158717 DOI: 10.1001/Archneurol.2011.2855  0.415
2011 Kim JY, Park KD, Richman DP. Treatment of myasthenia gravis based on its immunopathogenesis. Journal of Clinical Neurology (Seoul, Korea). 7: 173-83. PMID 22259613 DOI: 10.3988/Jcn.2011.7.4.173  0.32
2003 Richman DP, Agius MA. Treatment of autoimmune myasthenia gravis. Neurology. 61: 1652-61. PMID 14694025 DOI: 10.1212/01.Wnl.0000098887.24618.A0  0.361
2003 Richman DP, Agius MA. Treatment principles in the management of autoimmune myasthenia gravis. Annals of the New York Academy of Sciences. 998: 457-72. PMID 14592915 DOI: 10.1196/Annals.1254.060  0.385
2003 Agius MA, Richman DP, Fairclough RH, Aarli J, Gilhus NE, Romi F. Three forms of immune myasthenia. Annals of the New York Academy of Sciences. 998: 453-6. PMID 14592914 DOI: 10.1196/Annals.1254.059  0.384
1998 Fairclough RH, Twaddle GM, Gudipati E, Lin MY, Richman DP. Differential surface accessibility of α(187-199) in the torpedo acetylcholine receptor α subunits Journal of Molecular Biology. 282: 317-330. PMID 9735290 DOI: 10.1006/Jmbi.1998.2001  0.313
1998 Fairclough RH, Twaddle GM, Gudipati E, Stone RJ, Richman DP, Burkwall DA, Josephs R. Mapping the mAb 383C epitope to alpha 2(187-199) of the Torpedo acetylcholine receptor on the three-dimensional model. Journal of Molecular Biology. 282: 301-15. PMID 9735289 DOI: 10.1006/Jmbi.1998.2000  0.329
1998 Kirvan CA, Zhu S, Richman DP, Agius MA. Expression and initial characterization of recombinant antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravis Annals of the New York Academy of Sciences. 841: 466-468. PMID 9668275 DOI: 10.1111/J.1749-6632.1998.Tb10963.X  0.386
1998 Richman DP, Agius MA, Kirvan CA, Gomez CM, Fairclough RH, Dupont BL, Maselli RA. Antibody effector mechanisms in myasthenia gravis. The complement hypothesis. Annals of the New York Academy of Sciences. 841: 450-65. PMID 9668274 DOI: 10.1111/J.1749-6632.1998.Tb10962.X  0.344
1998 Lin MY, Twaddle GM, Gudipati E, Richman DP, Fairclough RH. MAb 383C binds to the α-subunit of the acetylcholine receptor associated with the high-affinity tubocurarine site Annals of the New York Academy of Sciences. 841: 101-103. PMID 9668226 DOI: 10.1111/J.1749-6632.1998.Tb10914.X  0.301
1994 Richman DP, Agius MA. Acquired myasthenia gravis: Immunopathology Neurologic Clinics. 12: 273-284. PMID 8041342 DOI: 10.1016/S0733-8619(18)30097-5  0.385
1993 Agius MA, Sanyal B, Richman DP. Molecular structure of a monoclonal antiacetylcholine receptor antibody and of a corresponding monoclonal antiidiotopic antibody Annals of the New York Academy of Sciences. 681: 274-275. PMID 8357167 DOI: 10.1111/J.1749-6632.1993.Tb22892.X  0.367
1993 Richman DP, Wollmann RL, Maselli RA, Gomez CM, Corey AL, Agius MA, Fairclough RH. Effector mechanisms of myasthenic antibodies. Annals of the New York Academy of Sciences. 681: 264-73. PMID 8357166 DOI: 10.1111/J.1749-6632.1993.Tb22891.X  0.333
1993 Xu Q, Fairclough H, Richman DP. Effects of D-penicillamine on multiple immunogenic epitopes of the acetylcholine receptor Annals of the New York Academy of Sciences. 681: 335-338. PMID 7689309 DOI: 10.1111/J.1749-6632.1993.Tb22911.X  0.324
1993 Xu Q, Twaddle GM, Richman DP, Fairclough RH. Characterization of the epitope of an antiacetylcholine receptor antibody that inhibits fifty percent of alpha-bungarotoxin binding Annals of the New York Academy of Sciences. 681: 175-178. PMID 7689304 DOI: 10.1111/J.1749-6632.1993.Tb22885.X  0.366
1993 Xu Q, Fairclough RH, Richman DP. Interaction of antiacetylcholine receptor monoclonal antibodies with the acetylcholine receptor Annals of the New York Academy of Sciences. 681: 172-174. PMID 7689303 DOI: 10.1111/J.1749-6632.1993.Tb22884.X  0.371
1991 Maselli RA, Richman DP, Wollmann RL. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology. 41: 1497-504. PMID 1891103 DOI: 10.1212/Wnl.41.9.1497  0.342
1989 Maselli RA, Nelson DJ, Richman DP. Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate Journal of Physiology. 411: 271-283. PMID 2614725 DOI: 10.1113/Jphysiol.1989.Sp017573  0.339
1989 Chinchetru MA, Marquez J, Garcia-Borron JC, Richman DP, Martinez-Carrion M. Interaction of nicotinic acetylcholine receptor with two monoclonal antibodies recognizing different epitopes Biochemistry. 28: 4222-4229. PMID 2475163 DOI: 10.1021/Bi00436A015  0.36
1988 Maselli RA, Jow B, Richman DP, Nelson DJ. In vitro blockade of neuromuscular transmission by monoclonal anti-acetylcholine receptor antibodies Annals of the New York Academy of Sciences. 540: 523-524. PMID 2849901 DOI: 10.1111/J.1749-6632.1988.Tb27158.X  0.389
1987 Blair DA, Mihovilovic M, Agius MA, Fairclough RH, Richman DP. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia. Annals of the New York Academy of Sciences. 505: 155-67. PMID 3500665 DOI: 10.1111/J.1749-6632.1987.Tb51289.X  0.419
1987 Stefansson K, Dieperink ME, Richman DP, Marton LS. Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: A possible role in the pathogenesis of myasthenia gravis Annals of the New York Academy of Sciences. 505: 451-460. PMID 2446557 DOI: 10.1111/J.1749-6632.1987.Tb51315.X  0.324
1987 Agius MA, Richman DP. Antiidiotopic modification of the anti-acetylcholine receptor immune response and of experimental autoimmune myasthenia gravis in Lewis rats Annals of the New York Academy of Sciences. 505: 896-897. DOI: 10.1111/J.1749-6632.1987.Tb51405.X  0.341
1987 DuPont BL, Richman DP. Complement activation by anti-acetylcholine receptor monoclonal antibody in vitro correlates with potency of EAMG response in vivo Annals of the New York Academy of Sciences. 505: 725-727. DOI: 10.1111/J.1749-6632.1987.Tb51351.X  0.374
1987 Yuen EC, Agius MA, Corey AL, Richman DP. Modification of experimental autoimmune myasthenia gravis with anti-idiotopic antibody administered after immunization with antigen Journal of Neuroimmunology. 16: 191-192. DOI: 10.1016/0165-5728(87)90429-2  0.349
1987 Fairclough RH, Richman DP. Mapping functional domains on the acetylcholine receptor using monoclonal antibodies and small angle X-ray diffraction Journal of Neuroimmunology. 16: 54-55. DOI: 10.1016/0165-5728(87)90211-6  0.31
1987 Fairclough RH, Mihovilovic M, Kezdy FJ, Richman DP. Monoclonal antibodies against two peptide sequences of the acetylcholine receptor distinguish between toxin binding and cholinergic ligand binding Journal of Neuroimmunology. 16: 54. DOI: 10.1016/0165-5728(87)90210-4  0.335
1986 Blair DA, Richman DP, Taves CJ, Koethe S. Monoclonal antibodies to acetylcholine receptor secreted by human x human hybridomas derived from lymphocytes of a patient with myasthenia gravis Immunological Investigations. 15: 351-364. PMID 3759150 DOI: 10.3109/08820138609052954  0.377
1985 Corey AL, Richman DP, Shuman CA, Gomez CM, Arnason BG. Use of monoclonal antiacetylcholine receptor antibodies to investigate the macrophage inflammation of acute experimental myasthenia gravis: refractoriness to a second episode of acute disease. Neurology. 35: 1455-60. PMID 3875805 DOI: 10.1212/Wnl.35.10.1455  0.373
1985 Stefansson K, Dieperink ME, Richman DP, Gomez CM, Marton LS. Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of Myasthenia gravis New England Journal of Medicine. 312: 221-225. PMID 2578213 DOI: 10.1056/Nejm198501243120407  0.319
1984 Gomez CM, Wollmann RL, Richman DP. Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor. Acta Neuropathologica. 63: 131-43. PMID 6610275 DOI: 10.1007/Bf00697195  0.343
1984 Donnelly D, Mihovilovic M, Gonzalez-Ros JM, Ferragut JA, Richman D, Martinez-Carrion M. A noncholinergic site-directed monoclonal antibody can impair agonist-induced ion flux in Torpedo californica acetylcholine receptor. Proceedings of the National Academy of Sciences of the United States of America. 81: 7999-8003. PMID 6096872 DOI: 10.1073/Pnas.81.24.7999  0.357
1982 Gomez CM, Richman DP. Anti-acetylcholine receptor antibodies directed against the α-bungarotoxin binding site induce a unique form of experimental myasthenia Proceedings of the National Academy of Sciences of the United States of America. 80: 4089-4093. PMID 6575398 DOI: 10.1073/Pnas.80.13.4089  0.406
1981 Gomez CM, Richman DP, Burres SA, Arnason BG, Berman PW, Fitch FW. Monoclonal hybridoma anti-acetylcholine receptor antibodies: antibody specificity and effect of passive transfer. Annals of the New York Academy of Sciences. 377: 97-109. PMID 6978667 DOI: 10.1111/J.1749-6632.1981.Tb33726.X  0.375
1981 Richman DP, Antel JP, Burns JB, Arnason BG. Nicotinic acetylcholine receptor on human lymphocytes. Annals of the New York Academy of Sciences. 377: 427-35. PMID 6951484 DOI: 10.1111/J.1749-6632.1981.Tb33750.X  0.31
1981 Burres SA, Crayton JW, Gomez CM, Richman DP. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: Clinical and electrophysiological aspects Annals of Neurology. 9: 563-568. PMID 6167199 DOI: 10.1002/Ana.410090609  0.406
1981 Gomez CM, Richman D. 5 INABILITY OF SOME ANTI-ACHR MONOCLONAL ANTIBODIES TO INDUCE MYASTHENIA Journal of Neuropathology and Experimental Neurology. 40: 300. DOI: 10.1097/00005072-198105000-00012  0.339
1980 Richman DP, Gomez CM, Berman PW, Burres SA, Fitch FW, Arnason BG. Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia. Nature. 286: 738-9. PMID 7412861 DOI: 10.1038/286738A0  0.415
1979 Richman DP, Antel JP, Patrick JW, Arnason BG. Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic site. Neurology. 29: 291-6. PMID 571972 DOI: 10.1212/Wnl.29.3.291  0.354
1979 Gomez CM, Richman DP, Berman PW, Burres SA, Arnason BG, Fitch FW. Monoclonal antibodies against purified nicotinic acetylcholine receptor. Biochemical and Biophysical Research Communications. 88: 575-82. PMID 465055 DOI: 10.1016/0006-291X(79)92087-4  0.403
1979 Richman DP, Arnason BG. Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 76: 4632-5. PMID 291991 DOI: 10.1073/Pnas.76.9.4632  0.335
1976 Richman DP, Patrick J, Arnason BG. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. The New England Journal of Medicine. 294: 694-8. PMID 129705 DOI: 10.1056/Nejm197603252941304  0.356
Show low-probability matches.